spacer
home > ebr > winter 2002 > stem cells find a uk niche - the uk national stem cell initiative
PUBLICATIONS
European Biopharmaceutical Review

Stem Cells Find a UK Niche - The UK National Stem Cell Initiative

Until a few years ago, stem cells were the province of developmental biologists in academic laboratories. They now represent the hottest scientific and possibly commercial property of all the life sciences. Until recently, the clinical potential of stem cells was only in the narrow field of adult haematopoiesis. Now they are heralded as a treatment for a range of intractable diseases from cancer to Alzheimer's.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr John Sinden, Chief Scientific Officer of ReNeuron Holdings plc John Sinden was formerly Reader in Neurobiology of Behaviour at King's College London with a special expertise in neural transplantation. With two colleagues, he founded ReNeuron in 1997, joined the company as Chief Scientific Officer in 1998 and saw the company through a successful flotation on LSE AIM in late 2000.
He is Co-ordinator on the largest EC FP5-funded stem cell grant and occasionally advises the UK Government, its agencies and the EC on scientific, industrial and ethical issues in the stem cell field.

spacer
Dr John Sinden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter MMCTs)
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement